Partha Basu/LinkedIn
Jul 1, 2025, 18:33
Partha Basu Shares IARC Study Linking Vaginal Microbiome to Cervical Precancer Treatment Outcomes
Partha Basu, Head of the Early Detection, Prevention and Infections Branch at IARC – International Agency for Research on Cancer / World Health Organization, shared on LinkedIn:
“I am very pleased to share with you our latest publication on the correlation between vaginal microbiome and success of cervical precancerous treatment. This study concluded that a vaginal microbiome profile dominated by Lactobacillus may serve as a potential biomarker for positive treatment responses.
Therapeutic approaches, such as probiotics, could help regulate the vaginal microbiome, enhance HPV clearance, and promote the regression of cervical precancer lesions. IARC is setting up further large-scale,multicentric studies to address the challenges of cervical precancer treatment among women living with HIV.”
More posts featuring Partha Basu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 28, 2025, 16:51
Jul 28, 2025, 16:51
Jul 28, 2025, 16:50
Jul 28, 2025, 16:47
Jul 28, 2025, 16:43
Jul 28, 2025, 16:32
Jul 28, 2025, 16:29
Jul 28, 2025, 16:15
Jul 28, 2025, 16:14
Jul 28, 2025, 15:57